Anti Ri paraneoplastic syndrome: clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Anti Ri paraneoplastic syndrome: clinical features. Women account for 78% of cases. Fully referenced neurology checklist.
Demographic features
- Women account for 78% of cases
- It is usually associated with breast or small cell lung cancers
Clinical patterns
Locked: subscribe to see this section.
Movement disorders
Locked: subscribe to see this section.
Other clinical features
Locked: subscribe to see this section.
Differential diagnosis
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Simard C, Vogrig A, Joubert B, et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamm 2020; pii: e699.
- Mancuso M, Orsucci D, Bacci A, Caldarazzo Ienco E, Siciliano G. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature. Arch Ital Biol 2011; 149:318-322.
- Weizman DA, Leong WL. Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature. J Surg Oncol 2004; 87:143-145.
- Wirtz PW, Sillevis Smitt PA, Hoff JI, et al. Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J Neurol 2002; 249:1710-1712.
- Martinaud O, Guegan-Massardier E, Iasci L, Miret N, Mihout B, Hannequin D. Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia. Rev Neurol (Paris) 2005; 161:81-86.
- And 8 more. Subscribe to see the full list
